Controlling alpha for mixed effects models for repeated measures

被引:1
|
作者
Ye, Zhishen [1 ]
Bekele, B. Nebiyou [1 ]
机构
[1] Gilead Sci Inc, Dept Biostat, 353 Lakeside Dr, Foster City, CA 94404 USA
关键词
Alpha control; clinical trials; group sequential testing; interim analysis; MMRM; CLINICAL-TRIALS;
D O I
10.1080/10543406.2018.1439052
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Mixed Effects Models for Repeated Measures (MMRM) is often used in clinical trials with longitudinal data. However, there has not been an in-depth examination available on how investigators can implement interim analysis while also controlling the overall alpha for clinical trials under an MMRM analysis framework. Statistical independence among measurements, which is often assumed in group sequential testing (GST), is not valid under an MMRM framework due to the correlations induced by longitudinal within-subject measurements. Therefore, methods associated with GST derived under independence need to be adjusted accordingly. While these correlations can be estimated from the study data, regulatory agencies may not accept results based on these estimated correlations since there is no guarantee that the overall alpha is strongly controlled. In this article, we propose a new AC-Hybrid-approach for controlling the overall alpha. The AC-Hybrid-approach has two key attributes. First, we apply the MMRM analysis framework on all available data at every analysis timepoint. Second, we use complete-case information fractions to derive the group sequential stopping boundaries. We prove that the overall alpha is controlled regardless of the correlations among within-subject measurements. We also show the impact of this approach on the alpha and the power through examples.
引用
收藏
页码:1055 / 1077
页数:23
相关论文
共 50 条
  • [1] On the practical application of mixed effects models for repeated measures to clinical trial data
    Andersen, Scott W.
    Millen, Brian A.
    PHARMACEUTICAL STATISTICS, 2013, 12 (01) : 7 - 16
  • [2] Effect of heteroscedasticity between treatment groups on mixed-effects models for repeated measures
    Gosho, Masahiko
    Maruo, Kazushi
    PHARMACEUTICAL STATISTICS, 2018, 17 (05) : 578 - 592
  • [3] Bayesian Method of Borrowing Study-Level Historical Longitudinal Control Data for Mixed-Effects Models with Repeated Measures
    Li, Hong
    Jin, Man
    Chung, Yu-Che
    Zhong, Sheng
    Wang, Li
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2023, 57 (01) : 142 - 151
  • [4] Dose-Response Mixed Models for Repeated Measures - a New Method for Assessment of Dose-Response
    Wellhagen, Gustaf J.
    Hamren, Bengt
    Kjellsson, Maria C.
    Astrand, Magnus
    PHARMACEUTICAL RESEARCH, 2020, 37 (08)
  • [5] Closed-form REML estimators and sample size determination for mixed effects models for repeated measures under monotone missingness
    Tang, Yongqiang
    STATISTICS IN MEDICINE, 2017, 36 (13) : 2135 - 2147
  • [6] Multiple imputation of missing repeated outcome measurements did not add to linear mixed-effects models
    Peters, Sanne A. E.
    Bots, Michiel L.
    den Ruijter, Hester M.
    Palmer, Mike K.
    Grobbee, Diederick E.
    Crouse, John R., III
    O'Leary, Daniel H.
    Evans, Gregory W.
    Raichlen, Joel S.
    Moons, Karel G. M.
    Koffijberg, Hendrik
    JOURNAL OF CLINICAL EPIDEMIOLOGY, 2012, 65 (06) : 686 - 695
  • [7] Equivalence and Noninferiority Testing in Regression Models and Repeated-Measures Designs
    Mascha, Edward J.
    Sessler, Daniel I.
    ANESTHESIA AND ANALGESIA, 2011, 112 (03) : 678 - 687
  • [8] Improving the mixed model for repeated measures to robustly increase precision in randomized trials
    Wang, Bingkai
    Du, Yu
    INTERNATIONAL JOURNAL OF BIOSTATISTICS, 2024, 20 (02) : 585 - 598
  • [9] Type-I-error rate inflation in mixed models for repeated measures caused by ambiguous or incomplete model specifications
    Haeckl, Sebastian
    Koch, Armin
    Lasch, Florian
    PHARMACEUTICAL STATISTICS, 2023, 22 (06) : 1046 - 1061
  • [10] Handling Baselines in Repeated Measures Analyses with Missing Data at Random
    Dinh, Phillip
    Yang, Peiling
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2011, 21 (02) : 326 - 341